{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T10:19:24Z","timestamp":1771755564191,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.jconrel.2011.09.096","type":"journal-article","created":{"date-parts":[[2011,10,12]],"date-time":"2011-10-12T16:34:43Z","timestamp":1318437283000},"page":"44-52","source":"Crossref","is-referenced-by-count":40,"title":["Synthesis, characterization and evaluation of bone targeting salmon calcitonin analogs in normal and osteoporotic rats"],"prefix":"10.1016","volume":"158","author":[{"given":"Krishna Hari","family":"Bhandari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhuri","family":"Newa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jillian","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Doschak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2011.09.096_bb0005","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2011.09.096_bb0010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/bbrc.2000.2294","article-title":"Effect of e-calcitonin on oeteoinduction by recombinant human bone morphogenetic perotein-2","volume":"269","author":"Okubo","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0168-3659(02)00238-9","article-title":"Preparation and evaluation of proliposomes containing salmon calcitonin","volume":"84","author":"Song","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.09.096_bb0020","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1210\/jcem-72-2-344","article-title":"Dose response bioactivity and bioavailability of salmon calcitonin in premenopausal and postmenopausal women","volume":"72","author":"Overgaard","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/biot.200900218","article-title":"PEGylation of therapeutic proteins","volume":"5","author":"Jevsevar","year":"2010","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0030","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1517\/14728210902907847","article-title":"Emerging PEGylated drugs","volume":"14","author":"Kang","year":"2009","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.jconrel.2011.09.096_bb0035","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2011.09.096_bb0040","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/bit.21482","article-title":"Size comparison between proteins PEGylated with branched and linear poly(ethylene glycol) molecules","volume":"98","author":"Fee","year":"2007","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0045","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10717540600814402","article-title":"Pharmacokinetic consequences of PEGylation","volume":"13","author":"Hamidi","year":"2006","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0050","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2010.10.004","article-title":"PK\/PD modelling of comb-shaped PEGylated salmon calcitonin conjugates of differing molecular weights","volume":"149","author":"Ryan","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.09.096_bb0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/8756-3282(85)90051-1","article-title":"Cytoskeleton rearrangements during calcitonin-induced changes in osteoclast motility in vitro","volume":"6","author":"Warshafsky","year":"1985","journal-title":"Bone"},{"key":"10.1016\/j.jconrel.2011.09.096_bb0060","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2174\/092986730611220401164504","article-title":"Calcitonin","volume":"6","author":"Sexton","year":"1999","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0065","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1210\/me.6.4.551","article-title":"A recombinant calcitonin receptor independently stimulates 3, 5-cyclic adenosine monophosphate and Ca2+\/inositol phosphate signaling pathways","volume":"6","author":"Chabre","year":"1992","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0070","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1083\/jcb.85.3.682","article-title":"Direct in vivo demonstration by radioautography of specific binding sites for calcitonin in skeletal and renal tissues of the rat","volume":"85","author":"Warshawsky","year":"1980","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0075","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.2983422","article-title":"Interaction of calcitonin and calcitonin gene-related peptide at receptor sites in target tissues","volume":"227","author":"Goltzman","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2011.09.096_bb0080","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1073\/pnas.78.6.3973","article-title":"Characterization of specific receptors for calcitonin in porcine lung","volume":"78","author":"Fouchereau","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0085","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1042\/bj2500877","article-title":"Human placental calcitonin receptors","volume":"250","author":"Nicholson","year":"1988","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0090","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1172\/JCI116046","article-title":"Cloning, characterization and expression of a human calcitonin receptor from an ovarian carcinoma cell line","volume":"90","author":"Gorn","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0095","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/jcem-65-4-742","article-title":"Identification of calcitonin receptors in human spermatozoa","volume":"65","author":"Silvestroni","year":"1987","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0100","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1248\/cpb.48.1921","article-title":"Pharmacokinetic disposition of polyethylene glycol-modified salmon calcitonin","volume":"48","author":"Yoo","year":"2000","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0105","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1359\/jbmr.2000.15.5.936","article-title":"Selective drug delivery system to bone: small peptide (Asp)6 conjugation","volume":"15","author":"Kasugai","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0110","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2165\/00003088-200342150-00002","article-title":"Bone-specific drug delivery systems: approaches via chemical modification of bone-seeking agents","volume":"42","author":"Hirabayashi","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bmc.2009.12.041","article-title":"Design, synthesis, and biological evaluation of novel estradiol-bisphosphonate conjugates as bone-specific estrogens","volume":"18","author":"Morioka","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0120","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.addr.2004.12.011","article-title":"Bone-targeting macromolecular therapeutics","volume":"57","author":"Wang","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0125","series-title":"Bone Scanning in Clinical Practice","first-page":"7","article-title":"99mTc diphosphonate uptake mechanism on bone","author":"Fancis","year":"1987"},{"key":"10.1016\/j.jconrel.2011.09.096_bb0130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2165\/00002512-199711050-00007","article-title":"Samarium 153Sm lexidronam","volume":"11","author":"Lamb","year":"1997","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jconrel.2011.09.096_bb0135","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1021\/bc034090j","article-title":"Synthesis of polymeric bone-targeting drug delivery systems","volume":"14","author":"Wang","year":"2003","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0140","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.addr.2004.12.015","article-title":"Designing proteins for bone targeting","volume":"57","author":"Gittens","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0145","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1432-1033.1994.tb18832.x","article-title":"Correlations between biological activities and conformational properties for human, salmon, eel, porcine calcitonins and Elcatonin elucidated by CD spectroscopy","volume":"221","author":"Siligardi","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0150","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1021\/bi00291a005","article-title":"Amphipathic helix and its relationship to the interaction of calcitonin with phospholipids","volume":"22","author":"Epand","year":"1983","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2011.09.096_bb0155","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/BF01937791","article-title":"Structure-activity relationship of human calcitonin III. Biological activity of synthetic analogs with shortened or terminally modified peptide chains","volume":"32","author":"Rittel","year":"1976","journal-title":"Experientia"},{"key":"10.1016\/j.jconrel.2011.09.096_bb0160","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1210\/endo-123-3-1483","article-title":"Biologically active, derivatizable salmon calcitonin analog: design, synthesis and applications","volume":"123","author":"D'Santos","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.jconrel.2011.09.096_bb0165","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s11095-011-0376-y","article-title":"Antibody-mediated \"universal\" osteoclast targeting platform using calcitonin as a model drug","volume":"28","author":"Newa","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0170","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1021\/mp8002368","article-title":"Improved bone delivery of osteoprotegerin by bisphosphonate conjugation in a rat model of osteoarthritis","volume":"6","author":"Doschak","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jsbi.1995.1024","article-title":"Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin","volume":"115","author":"Bauer","year":"1995","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0180","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1073\/pnas.84.23.8340","article-title":"Biological and physical properties of a model calcitonin containing a glutamate residue interrupting the hydrophobic face of the idealized amphiphilic alpha-helical region","volume":"84","author":"Green","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/protein\/9.3.265","article-title":"Analysis of protein conformational characteristics related to thermostability","volume":"9","author":"Querol","year":"1996","journal-title":"Protein Eng."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0190","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0378-3812(93)87148-T","article-title":"Theory for protein solubilities","volume":"82","author":"Stigter","year":"1993","journal-title":"Fluid Phase Equilib."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0215","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1021\/j100189a013","article-title":"Theory for the aggregation of proteins and copolymers","volume":"96","author":"Fields","year":"1992","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0200","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2010.04.015","article-title":"Synthesis, characterization and in vitro evaluation of a bone targeting delivery system for salmon calcitonin","volume":"394","author":"Bhandari","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0205","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0006-291X(80)91193-6","article-title":"Calcitonin receptors in a cloned human breast cancer cell line (MCF-7)","volume":"96","author":"Martin","year":"1980","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2011.09.096_bb0210","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s002239900345","article-title":"Intrapulmonary drug delivery of salmon calcitonin","volume":"61","author":"Deftos","year":"1997","journal-title":"Calcif. Tissue Int."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365911009503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365911009503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T12:09:01Z","timestamp":1686398941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365911009503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0168365911009503"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2011.09.096","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}